Today's GLP-1 therapies represent one of medicine's most significant advances in metabolic health
A Danish and Norwegian cohort study of over 424,000 patients found that semaglutide use more than doubled the risk of NAION compared to patients taking other diabetes medications
Um, and then people who, um, You know, have active, pretty, intense, disordered eating
Comparing the medications side by side for alternating decisions This comparison table helps visualize the key differences that affect alternating protocols: For a detailed comparison of how these medications stack up across additional factors, the semaglutide versus tirzepatide comparison page provides comprehensive analysis
Patients who use the drugs as an extra boost to lose weight can face criticism that theyre somehow cheating, said Dr